Elenco degli articoli con argomento «cancro»

Dermatologia

07 mag 2018

Cumulative exposure to biologics and risk of cancer in psoriasis patients: A meta-analysis of Psonet studies from Israel, Italy, Spain, UK navigation-next-alternate

Objectives: to assess a dose-response relationship between cumulative length of exposure to biologic therapy and risk of cancer.

05 dic 2017

AJCC Cancer Staging System Manual, 8th Edition

Melanoma Staging: Evidence-Based Changes in the American Joint Committee on Cancer (AJCC) Eighth Edition Cancer Staging Manual

13 giu 2017

Larotrectinib Shows Durable Antitumour Activity in TRK Fusion Cancers Across a Wide Range of Tumour Types navigation-next-alternate

Larotrectinib has demonstrated consistent and durable antitumor activity in tropomysin receptor kinase (TRK) fusion cancers, across a wide range of ages and tumour types, and was well-tolerated, according to a study presented here at the 2017 Annual Meeting of the American Society of Clinical Oncology (ASCO)

18 apr 2017

Avelumab Provides Durable Responses in Patients With Distant Metastatic Merkel Cell Carcinoma navigation-next-alternate

Avelumab provided durable responses in patients with distant metastatic Merkel cell carcinoma who had progressed after chemotherapy, according to a study presented here at the 2017 Annual Meeting of the American Association for Cancer Research (AACR)

10 apr 2017

New Gene-Based Blood Tests Identify More Skin Cancers navigation-next-alternate

Genetic testing of tumour and blood fluid samples from people with and without one of the most aggressive forms of skin cancer has shown that 2 new blood tests can reliably detect previously unidentifiable forms of the disease

13 mar 2017

Patients Aged Older Than 85 Years Who Have Mohs Surgery Average 6 More Years of Life navigation-next-alternate

Patients aged older than 85 years can safely undergo Mohs micrographic surgery to remove non-melanoma skin cancer and still have years of good quality of life, researchers reported here at the 75th Annual Meeting of the American Academy of Dermatology (AAD)

17 feb 2017

Scalp Cooling Device May Help Reduce Chemotherapy-Induced Hair Loss navigation-next-alternate

Two studies published in the February 14 issue of JAMA showed that using a scalp cooling device before, during, and after chemotherapy reduced hair loss among women with breast cancer

17 ott 2016

Cheratosi attinica per 400mila italiani: ecco perché è impossibile prevedere chi è a rischio di cancro navigation-next-alternate

Chi soffre di cheratosi attinica ha lesioni pre-cancerose poco pericolose, conseguenza di un'esposizione prolungata ai raggi ultravioletti, che possono però evolvere in carcinoma invasivo. Gli esperti: «Il trattamento tempestivo è fondamentale»

26 set 2016

Skin Cancer a Risk for Nonwhite Recipients of Organ Transplants navigation-next-alternate

A total-body skin examination should be part of post-transplant care for all organ recipients because they have a higher risk of skin cancer, including nonwhite patients, according to a study published online by JAMA Dermatology.

13 ago 2016

Poor Skin Cancer Survival in Patients With Skin of Colour navigation-next-alternate

Because Caucasians have a higher skin cancer risk than the general population, people with skin of colour may believe that they don't need to be concerned about this disease -- but new research reveals this to be a dangerous misconception.

30 lug 2016

USPSTF Does Not Recommend Visual Skin Examination by a Clinician to Screen for Skin Cancer navigation-next-alternate

The US Preventive Services Task Force (USPSTF) has concluded that the current evidence is insufficient to assess the balance of benefits and harms of visual skin examination by a clinician to screen for skin cancer in asymptomatic adults

11 giu 2016

Il cancro ha 50 talloni d'Achille, svelati nuovi geni bersaglio navigation-next-alternate

Il cancro è più fragile grazie a uno studio dell'Istituto europeo di oncologia di Milano. In un lavoro condotto su casi di melanoma metastatico, gli scienziati dell'Irccs hanno scoperto che il tumore cresce per effetto della deregolazione di oltre 50 geni e può quindi essere attaccato da più parti